Suppr超能文献

每5年注射一次破伤风加强针:一项不必要的常规操作?

Tetanus booster every 5 years: an unnecessary routine?

作者信息

Chikhani C G, Kumar K

机构信息

Department of Accident and Emergency Medicine, Milton Keynes General Hospital, England.

出版信息

Arch Emerg Med. 1988 Mar;5(1):4-11. doi: 10.1136/emj.5.1.4.

Abstract

The various guidelines for the administration of tetanus toxoid and antitetanus immunoglobulin are not only complicated, but also have never been supported by any scientific experimental studies. This study has measured the antibody levels in a random sample of 157 patients presenting to an accident and emergency department. Levels were measured before and after boosting doses. The results show that, in the sample analyzed, even those patients who had their last 'booster' over 10 years ago, had a satisfactory immunoglobulin level. In fact, no patient in the study had a level below the 'protective level'. Bearing in mind the small number of patients in the study, it could be argued that the level of immunity against tetanus in the United Kingdom is likely to be higher than assumed. If this is proven to be correct, then the length of time between booster injections of toxoid can be extended and the use of Human Antitetanus Immunoglobulin can be further restricted.

摘要

破伤风类毒素和破伤风抗免疫球蛋白的各种管理指南不仅复杂,而且从未得到任何科学实验研究的支持。本研究对157名到急诊部门就诊的患者随机样本的抗体水平进行了测量。在加强剂量前后分别进行了测量。结果显示,在所分析的样本中,即使是那些最后一次“加强”超过10年前的患者,其免疫球蛋白水平也令人满意。事实上,研究中没有患者的水平低于“保护水平”。考虑到研究中的患者数量较少,可以认为英国的破伤风免疫水平可能高于预期。如果这被证明是正确的,那么类毒素加强注射之间的时间间隔可以延长,人破伤风免疫球蛋白的使用可以进一步受限。

相似文献

1
Tetanus booster every 5 years: an unnecessary routine?
Arch Emerg Med. 1988 Mar;5(1):4-11. doi: 10.1136/emj.5.1.4.
2
Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11.
3
[Preventive tetanus immunization and avoidance of side effects of booster immunization].
Dtsch Med Wochenschr. 1992 Dec 11;117(50):1903-6. doi: 10.1055/s-2008-1062527.
4
[Guidelines for the use of antitetanus vaccination].
Boll Ist Sieroter Milan. 1980 Nov 30;59(5):550-3.
5
A nonadjuvanted transcutaneous tetanus patch is effective in boosting anti-tetanus toxoid immune responses.
Clin Vaccine Immunol. 2014 Feb;21(2):253-5. doi: 10.1128/CVI.00638-13. Epub 2013 Dec 11.
7
Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response.
J Trauma. 1987 Dec;27(12):1358-61. doi: 10.1097/00005373-198712000-00007.
8
Immune responses of Asian elephants (Elephas maximus) to commercial tetanus toxoid vaccine.
Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):287-9. doi: 10.1016/j.vetimm.2009.08.005. Epub 2009 Aug 13.
10
Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines.
Lancet. 1979 Jun 30;1(8131):1364-8. doi: 10.1016/s0140-6736(79)92006-3.

本文引用的文献

1
LONG-TERM IMMUNITY TO TETANUS--A STATISTICAL EVALUATION AND ITS CLINICAL IMPLICATIONS.
Am J Public Health Nations Health. 1964 Jun;54(6):961-71. doi: 10.2105/ajph.54.6.961.
4
The uses and results of active tetanus immunization.
Bull World Health Organ. 1955;13(3):381-94.
5
Adequacy of antitetanus prophylaxis in six hospital emergency rooms.
N Engl J Med. 1983 Sep 15;309(11):636-40. doi: 10.1056/NEJM198309153091104.
6
Tetanus-toxoid emergency boosters: a reappraisal.
N Engl J Med. 1969 Mar 13;280(11):575-81. doi: 10.1056/NEJM196903132801102.
7
Duration of immunity after active immunisation against tetanus.
Lancet. 1969 Jul 12;2(7611):95-6. doi: 10.1016/s0140-6736(69)92404-0.
8
Misuse of tetanus immunoprophylaxis in wound care.
Ann Emerg Med. 1985 Jun;14(6):573-9. doi: 10.1016/s0196-0644(85)80783-6.
9
The prevention of tetanus: which direction for improvement?
Arch Emerg Med. 1986 Dec;3(4):221-3. doi: 10.1136/emj.3.4.221.
10
Prevention of tetanus in the wounded.
Br Med J. 1975 Aug 23;3(5981):453-5. doi: 10.1136/bmj.3.5981.453.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验